PIK3CA and non-small cell lung carcinoma: TKI could induce the formation of heterodimer of EGFR and IFG-1R in NSCLC cellular membrane, activate IFG-1R and its downstream signal transduction (PI3K/Akt), enhance anti-apoptosis effect and hence develop resistance to TKI [55].